Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.

NCT02546674 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Nilotinib

Sponsor

Novartis Pharmaceuticals